Abstract-The actions of angiotensin II type 2 receptor (AT 2 R) and the receptor Mas (MasR) are complex but show similar pronatriuretic function; particularly, AT 2 R expression and natriuretic function are enhanced in obese/diabetic rat kidney. In light of some reports suggesting a potential positive interaction between these receptors, we tested hypothesis that renal AT 2 R and MasR physically interact and are interdependent to stimulate cell signaling and promote natriuresis in obese rats. We found that infusion of AT 2 R agonist C21 in obese Zucker rats (OZR) increased urine flow and urinary Na excretion which were attenuated by simultaneous infusion of the AT 2 R antagonist PD123319 or the MasR antagonist A-779. Similarly, infusion of MasR agonist Ang-(1-7) in OZR increased urine flow and urinary Na excretion, which were attenuated by simultaneous infusion of A-779 or PD123319. Experiment in isolated renal proximal tubules of OZR revealed that both the agonists C21 and Ang-(1-7) stimulated NO which was blocked by either of the receptor antagonists. Dual labeling of AT 2 R and MasR in OZR kidney sections and human proximal tubule epithelial cells showed that AT 2 R and MasR are colocalized. The AT 2 R also coimmunoprecipitated with MasR in cortical homogenate of OZR. Immunoblotting of cortical homogenate cross-linked with zero-length oxidative (sulfhydryl groups) cross-linker cupric-phenanthroline revealed a shift of AT 2 R and MasR bands upward with overlapping migration for their complexes which were sensitive to the reducing β-mercaptoethanol, suggesting involvement of -SH groups in cross-linking. Collectively, the study reveals that AT 2 R and MasR are colocalized and functionally interdependent in terms of stimulating NO and promoting diuretic/ natriuretic response. (Hypertension. 2017;70:831-838.
M
any receptors make homo-or heterodimers and thereby regulate downstream signaling and cellular events. Therefore, studying such receptor phenomena and the mechanism(s) behind them has been considered an important step for drug development in pharmacotherapy. G proteincoupled receptors have proven to be a successful therapeutic target accounting for ≈30% to 50% marketed drugs. Angiotensin II (Ang-II) type 2 receptor (AT 2 R) [1] [2] [3] [4] and receptor Mas (MasR) [5] [6] [7] [8] [9] belong to nonclassical G protein-coupled receptor family 10 and mediate functions such as diuresis, natriuresis, vasorelaxation, and blood pressure reduction in various animal models. The AT 2 R 3 and MasR 5, 7, 11, 12 also show overlapping signaling in terms of nitric oxide (NO) formation and inhibiting Na + ,K + -ATPase activity in renal proximal tubules. Overall, both these receptors are considered as part of the protective arm of the renin-angiotensin system and have been implicated in improving disease phenotypes such as obesity, hypertension, and chronic kidney diseases, which are supported by pharmacological and knockout animal studies. 8, [13] [14] [15] [16] There is evidence showing that AT 2 R 17 and MasR 18, 19 form heterodimers with AT 1 R, and this heterodimerization provides a mechanism by which AT 2 R and MasR attenuate AT 1 R-induced signaling and cellular function. As it relates to an interaction between AT 2 R and MasR, several studies suggest that these receptors may be functionally interdependent. For example, AT 2 R antagonist PD123319 reduced vasodepressor effects of endogenous MasR agonist Ang-(1-7).
Although the AT 2 R knockout study indicates that an intact AT 2 R may be needed for MasR to function, 27 pharmacological studies raise a question whether AT 2 R or MasR ligands are specific or have overlapping affinity for these receptors. 28 Affinity profiles clearly suggest that MasR ligands have much higher affinity for MasR when compared with AT 2 R. Similarly, AT 2 R ligands have very high affinity for AT 2 R when compared with MasR. 28 Considering that AT 2 R and MasR ligands are preferential, a notion of physical interaction and thereby functional interdependence is a likely scenario. In support of such notion, molecular interactions between AT 2 R and MasR were demonstrated by fluorescence resonance energy transfer and cross-relation spectroscopy in human kidney-293 cells transiently transfected with vectors encoding fluorophore-tagged AT 2 R and MasR. 29 Numerous studies from our laboratory and others suggest that AT 2 R is upregulated and protective in the heart, kidney, and other tissues during pathological conditions, including obesity. 1 In obese animals, we have reported that AT 2 R stimulation promotes natriuresis 1 and protects against salt-sensitive hypertension. 30 Present study is designed to investigate whether AT 2 R-mediated natriuresis/diuresis is dependent on functional MasR or vice versa and whether these 2 receptors physically interact providing a potential molecular basis of functional interdependence. We observed that AT 2 R and MasR are constitutively colocalized in renal cortex of obese Zucker rat (OZR) kidney and may interact by forming disulfide bridges. Moreover, we have found that their signaling and function in terms of NO stimulation and diuretic-natriuretic response are interdependent.
Methods
Male OZR (9-10 weeks) were purchased from Harlan, Indianapolis, IN. After arrival, the animals were housed in the University of Houston animal care facility. Animal experimental protocols used in this study were approved by the IACUC at the University of Houston and adhere to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Details on various assay methods are available in the online-only Data Supplement.
Statistical Analysis
Data are presented as mean±SEM. The data were analyzed using GraphPad Prism 5, and differences were considered significant at P <0.05. Results were analyzed by 1-way ANOVA with repeated measures followed by Fisher LSD test (each comparison stands alone) or Friedman test followed by Dunn multiple comparison test.
Results

Coimmunoprecipitation Experiment
Coimmunoprecipitation (Co-IP) is a standard technique to identify whether protein(s) of interest are colocalized. We isolated AT 2 R and MasR complexes by immunoprecipitation with rabbit anti-MasR antibody in cortical homogenate of OZR followed by immunoblotting with rabbit anti-AT 2 R and goat anti-MasR antibodies. The data revealed that AT 2 R was coprecipitated with MasR ( Figure 1 ). Preliminary Co-IP experiment using normal rabbit immunoglobulin (nonspecific) followed by immunoblotting of their complexes did not show the presence of MasR or AT 2 R in cortical homogenate supporting the specificity of Co-IP experiments ( Figure S1A in the online-only Data Supplement). In this set of experiment, immunoprecipitates were eluted with glycine (pH 2.5). In subsequent experiments, we used Laemmli buffer containing β-mercaptoethanol as an eluent, Figure 1 . Coimmunoprecipitation (Co-IP) of angiotensin II type 2 receptor (AT 2 R)-receptor Mas (MasR) complex in renal cortical homogenate of male obese Zucker rat. Kidney homogenate was prepared as mentioned in Appendix S1 in the online-only Data Supplement, and supernatant was used for protein determination and Co-IP experiment. Renal cortical homogenate (500 μL, ≈1.5 mg protein) was incubated overnight with gentle rotation at 4°C with rabbit 1° anti-MasR antibody, (≈2 μg). Protein A/G agarose (20 μL) was added to antigen-antibody complex and incubated overnight at 4°C with gentle rotation. Protein A/G agarose was pulled down at 2500 rpm for 10 minute. Immunoprecipitates were washed with IP wash buffer (3×500 μL) and eluted with Laemmli buffer (50 μL), containing β-mercaptoethanol, separated on SDS-PAGE, 4% to 20% for MasR or 10% for AT 2 R, transferred to PVDF membrane, blocked with 5% milk-TBST and immunoblotted with goat anti-MasR (1:1000) or customsynthesized rabbit anti-AT 2 R (1:1000). Membranes were washed with TBST, reprobed with donkey anti-goat (1:4000) or goat anti-rabbit 2° antibody (1:3000), washed with TBST and analyzed via SuperSignal West Femto Maximum Sensitivity substrate. Results are representative of n=8. Only negative control sc-54848 showed nonspecific immunoreactivity. Negative control ab56018 did not show any significant immunoreactivity.
which provided better enrichment of immunoprecipitates. Co-IP was performed by 2 methods just to insure the validity of methods in our hand, (1) incubating homogenate with IP MasR antibody followed by protein A/G pulldown and (2) incubating IP MasR antibody with protein A/G complex followed by incubation with homogenate ( Figure  S1B ). Both techniques resulted in similar findings, that is, AT 2 R-and MasR-specific immunoreactivity is observed above and below nonspecific band of immunoglobulin subunit, that is, ≈50 kDa, respectively. Approximate molecular size of immunoreactive bands of AT 2 R and MasR was compared with bands directly measured in homogenate (lane 6, Figure S1B ). Remaining immunoreactivity at ≈ 100 and ≈25 kDa is nonspecific and shows the presence of immunoglobulin subunits. Specificity of rabbit anti-MasR antibody used to precipitate MasR in cortical homogenate was validated by knocking down MasR with siRNA in human proximal tubule epithelial cells (human kidney-2 [HK-2] cells; Figure S2 ). The custom-raised AT 2 R antibody was validated by siRNA knockdown of AT 2 R in left kidney of Sprague-Dawley rats as summarized in Figure S5 . In summary, Co-IP results show that AT 2 R coexisted with MasR in OZR kidney.
Dual-Labeling Experiments
Findings of Co-IP experiments were confirmed with dualimmunolabeling experiment in cryosections of OZR kidney tissue. AT 2 R antibody used in Western blot experiments did not yield clear results in immunohistochemistry experiment. Therefore, another commercially available AT 2 R antibody was used (ab19134, Abcam Inc) for immunohistochemistry experiments. Confocal laser scanning microscopy showed immunohistochemical colocalization of AT 2 R and MasR primarily in renal tubules, not in glomerulus of OZR. The presence of colocalization as yellow puncta seems to be scattered around cell including in the cytosolic compartments ( Figure 2 ). Such labeling is consistent to reports showing AT 2 R expression in nuclear 12, [31] [32] [33] and mitochondrial 31, 34 compartment of the cell. Another study suggested that AT 2 R predominantly is present in the cytosol and AT 2 R agonist triggers their translocation to the plasma membranes. 35 Incubation with secondary antibodies alone did not show colocalization indicating specificity of experiment ( Figure S3 ). Overall, the data support the concept of AT 2 R-MasR colocalization.
We also measured colocalization of AT 2 R and MasR in HK-2 cells. Unlike in the kidney, AT 2 R-MasR are colocalized in both membrane and cytoplasm mainly in perinuclear region ( Figure 3 ) and provides an overall better labeling. Moreover, the MasR-specific siRNA knockdown in HK-2 cells significantly reduced MasR expression and accordingly reduced colocalization with AT 2 R, showing specificity of the experiment. Notably, knockdown of MasR did not affect expression of AT 2 R (Figure 3 ). Together these results confirm that AT 2 R and MasR are colocalized in renal cortex of OZR and in HK-2 cells.
Cross-Linking Experiments
To examine the potential mechanism of physical interaction between AT 2 R and MasR, we performed cross-linking experiment using cupric-phenanthroline complex (CuP, 1.5:4, 0-300 μmol/L final concentration) in renal cortical homogenate of OZR (Figure 4 ). CuP can enter transmembrane pocket and selectively oxidize free thiol (-SH) groups of cysteine located in close proximity (<7 angstrom) facilitating formation of cysteine-cysteine disulfide bridges. Immunoblotting of CuP cross-linked proteins revealed nearly identical electrophoretic migration of AT 2 R-and MasR-specific complexes which were apparent between 135 and 180 kDa and slightly above 245 kDa range when compared with their monomers of (AT 2 R at 63 kDa; MasR at 54 kDa). These immunoreactive bands second and third from top seem to have same size for both antibodies and therefore may contain AT 2 R and MasR. Addition of a reducing agent β-mercaptoethanol completely reduced all higher bands into monomeric form (lane 9). Samples without β-mercaptoethanol and CuP showed monomeric and higher order bands (lane 2). Addition of CuP seems to convert all monomeric to higher order bands (lanes 3-8) .
We also performed cross-linking experiments using another amine-reactive cross-linker, disuccinimidyl tartrate. It is a water soluble periodate-sensitive cross-linker containing amine (1°)-reactive NHS ester ends and 4-atom spacer arm. Cross-linking of renal cortical homogenate with disuccinimidyl tartrate (1-5 mmol/L final concentration) followed by immunoblotting did not reveal AT 2 RMasR heteromers in cortical homogenate of OZR kidney ( Figure S4 ).
Diuresis-Natriuresis Experiment
Diuretic ( Figure 5A ) and natriuretic responses ( Figure 5B 
Experiments in Isolated Renal Proximal Tubules
To further support the renal functional results of diuresisnatriuresis, we measured cell signaling in isolated renal proximal tubules of OZR. We measured nitrites as a surrogate measure of NO formation, a common second messenger of 
Discussion
We demonstrate by Co-IP and confocal laser scanning microscopy that AT 2 R and MasR are constitutively colocalized in renal cortex of obese rat and HK-2 cells. Disulfide bridge formation seems to be a mechanism involved in forming/stabilizing colocalization of these receptors. We also demonstrate that AT 2 R and MasR are functionally interdependent in terms of NO formation and producing diuretic-natriuretic response in obese rats.
For many proteins which functionally interact, it is important that such proteins are localized in close proximity. Present study using confocal imaging and Co-IP approach clearly suggest that AT 2 R and MasR are expressed in close proximity and physically interact. Consistent with these observations, immunoblotting of CuP cross-linked renal cortical homogenate revealed significant overlapping of AT 2 R-and MasR-selective heteromers which were not seen after cross-linking with amine-reactive cross-linker, disuccinimidyl tartrate (4-atom spacer arm). Cross-linking approach further suggests the role of cysteine residues in forming heteromers via disulfide bridges which are further enhanced in the presence of oxidative conditions. It seems that close proximity allows these receptors to make cysteine bridges because absence of reducing agent mercaptoethanol shifted the bands of both the receptors from monomers to bands of higher order. This phenomenon is further enhanced by the oxidative agent CuP to the degree that all monomers were converted to the bands of higher order. AT 2 R has multiple cysteine residues. 36 Leonhardt et al 29 recently suggested that C35 of AT 2 R is essential for AT 2 R-MasR heterodimerization as FRET efficiency was found significantly decreased in HEK-293 cells transiently transfected with vectors encoding mutant AT 2 R-C35A-YFP and nonmutant MAS-CFP. Particularly, Cys35 of the N terminus in one and Cys290 of exoloop 3 of other AT 2 R played a role in constitutive homodimerization of AT 2 R via disulfide bridge formation. 36 Another study demonstrated that deletion of residues 240 to 244 within intermediate portion of cytoloop 3 resulted in a complete loss of AT 2 R-mediated effects. 37 Although present study reasonably indicates a role of cysteine residues in AT 2 R-MasR dimerization, mutagenesis experiments are required to precisely locate those cysteine residues and define their functional consequence on signaling and function of AT 2 R-MasR dimers. Collectively, multiple methodological approaches taken in this study provide a clear evidence that AT 2 R and MasR coexist as dimer. Present study does not allow to understand subcellular distribution and functional relevance of the dimer that warrants further studies.
Renal function experiment and treatment of isolated renal proximal tubules of OZR with preferential ligands of AT 2 R and MasR showed that they are functionally interdependent in producing diuretic-natriuretic response and NO formation. Functional interdependence observed in our study is in agreement with other studies showing abilities of AT 2 R antagonist to prevent the effects involving MasR and vice versa. [20] [21] [22] [23] [24] [25] [26] [27] 29, 38, 39 However, these in vivo and in vitro studies in isolated proximal tubule provide an interesting observation in that agonist activation of one receptor may not be critical for another receptor to function. This notion is supported by in vitro studies in isolated proximal tubules where either of the agonists alone AT 2 R agonist C21 or MasR agonist Ang-(1-7) was sufficient to increase NO formation. Blocking of C21 response on NO formation by the AT 2 R antagonist PD13319 is obvious that PD123319 displaces agonist binding, 28 but how MasR antagonist A-779 blocks C21 response is not clear. Because these ligands are quite selective, it may not be A-779 binding on AT 2 R at the concentration used in our experiments. The likely scenario is that these antagonists PD123319 and A-779 do not simply occupy the binding sites, rather they cause conformation change affecting receptor downward signaling or they prevent agonist-induced active conformation. This notion is supported by our recent FRET studies in HEK cells expressing AT 2 R and MasR that their agonists alone do not affect FRET, suggesting that these ligands do not promote or dissociate dimerization. 29 Along the same line of notion, other studies suggested that pretreatment of agonist or antagonist did not affect interactions of AT 2 R with AT 2 R, 36 AT 1 R, 40 or B 2 R. 41 Whereas numerous studies, including present study, indicated functional interdependency of AT 2 R and MasR, there are studies suggesting that these receptors may not be universally interdependent. 42, 43 For example, AT 2 R antagonist PD123319 did not abolish Ang-(1-7) inhibition of Na + -ATPase activity in isolated basolateral membrane of pig kidney. 42 The PD123319 did not affect Ang-(1-7)-induced decrease in renal blood flow in anesthetized dog. 43 Similarly MasR antagonist had no effect on AT 2 R-mediated pharmacotherapeutic actions. [44] [45] [46] Atheroprotective effect of AT 2 R agonist CGP42112a was opposed by PD123319 but not by the MasR antagonist A-779. 44 Also A-779 did not affect AT 2 R agonist CGP42112a-mediated secretion of atrial natriuretic peptide from isolated perfused rat atria. 45 It is not clear which physiological conditions, anatomic location, or cell types are conducive promoting AT 2 R-MasR dimerization and functional interdependence, but nuances in the chemical and functional properties of these 2 receptors are evident. AT 2 R and MasR are 2 emerging receptors in terms of their protective functions against AT 1 R-mediated antinatriuresis, hypertension, hypertrophy, and inflammation, and understanding function of AT 2 R and MasR at molecular level and nature of their functional synergy has a pathophysiological and translational significance.
In addition to providing cues of physiological functional interaction between AT 2 R and MasR in kidney of obese rats, the present study offers means to develop ligands that can selectively stimulate AT 2 R-MasR heteromers to enhance their ability in nitrite formation and diuretic-natriuresis response. In future, it would be interesting to study whether AT 2 R-MasR heterodimerization changed ligand affinity toward their preferential ligands. Because activation of both, AT 2 R and MasR, have been shown to lower blood pressure, it would be important to investigate whether cotreatment of AT 2 R agonist C21 and MasR agonist Ang-(1-7) produces synergistic reduction of blood pressure and renal injury in high salt-fed obese rats. Although our studies clearly demonstrate functional interdependence of AT 2 R and MasR, less obvious colocalization and dimerization aspects need further in-depth investigation, which can be considered a limitation of the current study.
Perspectives
Kidney is one of the prime targets which is adversely impacted by obesity and hypertension. Numerous therapeutic approaches are in use to alleviate kidney function. On the basis of our work and recent reports of heterodimerization of MasR with AT 1 R and B 2 R, and of AT 2 R with AT 1 R and B 2 R, it is clear that AT 2 R may constitutively heterodimerize in renal cortex of OZR. Such interactions may be critical to the net physio-and pharmacological responses. Understanding of mechanism of their interactions and functional interdependence offers an opportunity for the development of tailored molecules that can specifically activate AT 2 R-MasR heteromers in kidney. Such novel molecules modulating nitrite formation, diuresis, and natriuresis would be of prime importance in treating pathologies including salt-sensitive hypertension and myriad kidney diseases in obesity.
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